churbz: I think there is a "wait and see" attitude which BP has about LymPro. I think those BP doing AD trials are definitely interested, but are waiting to see how the additional LP002 72 patients being tested turns out, along with the 12 week validation test ICON is doing in their lab. That should all be completed in early December.

Gerald said marketing materials for Lympro were at the printers and will be used to make sure BP doing AD trials and General Practitioners in AD understand Lympro and it's strengths in screening patients. I think soft selling to BP is already going on and once the launch begins in December I think we'll start seeing BP doing AD trials sign up to use LymPro....thus beginning our pps rise.

Most new drugs take awhile to catch on. Same thing for the LymPro diagnostic. With Beckton Dickenson's validation and the fact LymPro is a third the cost of Amyvid....I don't think BP is rejecting LymPro at all. I think they are very much "waiting to see" the results in early December....and then blast off will occur.

That's what I'm betting on. That's what we're all betting on. That's what Gerald's job is hanging on!